Roohi Ismail‐Khan

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

Denise A. Yardley, Roohi Ismail‐Khan, Bohuslav Melichar et al. · Journal of Clinical Oncology · 2013 · 418 citations

Medicine, Oncology, Pharmacology +17

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

Pamela N. Münster, Kenneth T. Thurn, Scott Thomas et al. · British Journal of Cancer · 2011 · 390 citations · Full text

Medicine, Oncology, Pharmacology +16

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

Raza M. Alvi, Matthew J. Frigault, Michael G. Fradley et al. · Journal of the American College of Cardiology · 2019 · 344 citations · Full text

Life Sciences, Immunology, Oncology +17

Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer

Pamela N. Münster, Amy P. Moore, Roohi Ismail‐Khan et al. · Journal of Clinical Oncology · 2012 · 238 citations · Full text

Medicine, Endocrinology, Oncology +17

Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters

Richard R. Reich, Cecile A. Lengacher, Carissa B. Alinat et al. · Journal of Pain and Symptom Management · 2016 · 199 citations · Full text

Nursing, Oncology, Psychology +10